Iborra, Ignacio
Puig, Maria
Marín, Laura
Calafat, Margalida
Cañete, Fiorella
Quiñones, Carles
González-González, Laura
Cardona, Glòria
Mañosa, Míriam
Domènech, Eugeni http://orcid.org/0000-0002-2315-7196
Article History
Received: 22 November 2020
Accepted: 22 December 2020
First Online: 19 January 2021
Compliance with Ethical Standards
:
: LM has served as a speaker or has received research or education funding or advisory fees from Takeda and Janssen. MC has served as a speaker or has received research or education funding or advisory fees from Takeda, Janssen, Faes Farma, and MSD; FC has served as a speaker or has received research or education funding or advisory fees from Takeda, Janssen, MSD, and Ferring. MM has served as a speaker or has received research or education funding or advisory fees from FAES, Ferring MSD, AbbVie, Takeda and Janssen; ED has served as a speaker and has received research and educational funding and advisory fees from MSD, AbbVie, Takeda, Celltrion, Samsung Bioepis, Kern Pharma, Pfizer, Janssen, Celgene, Adacyte Therapeutics, Otsuka Pharmaceuticals, Ferring, Shire Pharmaceuticals, Tillots, Thermofisher, Grifols, Gilead, Roche and Gebro. The remaining authors declared no conflicts of interest.
Free to read: This content has been made available to all.